{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:37:08Z","timestamp":1790375828007,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.cgh.2017.09.031","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T18:01:42Z","timestamp":1506103302000},"page":"947-954.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B"],"prefix":"10.1016","volume":"16","author":[{"given":"Teng-Yu","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Town","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4207-2312","authenticated-orcid":false,"given":"Chun-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2017.09.031_bib1","first-page":"87","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cgh.2017.09.031_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","article-title":"Epidemiology of cholangiocarcinoma: an update focusing on risk factors","volume":"101","author":"Shin","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cgh.2017.09.031_bib3","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ajg.2012.173","article-title":"Biliary tract cancers in Olmsted County, Minnesota, 1976-2008","volume":"107","author":"Yang","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.09.031_bib4","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/sj.bjc.6603127","article-title":"Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001","volume":"94","author":"West","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cgh.2017.09.031_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.dld.2009.10.009","article-title":"Descriptive epidemiology of cholangiocarcinoma in Italy","volume":"42","author":"Alvaro","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2017.09.031_bib6","first-page":"3637","article-title":"Increasing incidence of cholangiocarcinoma in Crete 1992-2000","volume":"22","author":"Mouzas","year":"2002","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cgh.2017.09.031_bib7","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1158\/1055-9965.EPI-05-0811","article-title":"A\u00a0comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States","volume":"15","author":"McGlynn","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cgh.2017.09.031_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12072-012-9369-0","article-title":"A\u00a0nationwide population-based study shows increasing incidence of cholangiocarcinoma","volume":"7","author":"Lee","year":"2013","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2017.09.031_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2015.11.017","article-title":"Cholangiocarcinoma: current opinion on clinical practice diagnostic and therapeutic algorithms\u2014a review of the literature and a long-standing experience of a referral center","volume":"48","author":"Brandi","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2017.09.031_bib10","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.22310","article-title":"Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment","volume":"48","author":"Blechacz","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.09.031_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.dld.2009.12.008","article-title":"Cholangiocarcinoma: update and future perspectives","volume":"42","author":"Gatto","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2017.09.031_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.510250235","article-title":"Demonstration of duck hepatitis B virus in bile duct epithelial cells: implications for pathogenesis and persistent infection","volume":"25","author":"Nicoll","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.09.031_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1440-1746.2000.02079.x","article-title":"Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in\u00a0vivo","volume":"15","author":"Nicoll","year":"2000","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.09.031_bib14","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.3748\/wjg.v20.i19.5721","article-title":"Hepatitis B virus infection and intrahepatic cholangiocarcinoma","volume":"20","author":"Zhou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.09.031_bib15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/hep.24150","article-title":"Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan","volume":"53","author":"Fwu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.09.031_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2012.02.022","article-title":"Are common factors involved in the pathogenesis of primary liver cancers? a meta-analysis of risk factors for intrahepatic cholangiocarcinoma","volume":"57","author":"Palmer","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2017.09.031_bib17","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1440-1746.2012.07207.x","article-title":"Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review","volume":"27","author":"Li","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.09.031_bib18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/apt.12344","article-title":"Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B","volume":"38","author":"Singal","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.09.031_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.gastro.2014.03.048","article-title":"Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study","volume":"147","author":"Wu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.09.031_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1017\/S1744133109990351","article-title":"Evolution of Taiwan's health care system","volume":"6","author":"Rachel Lu","year":"2011","journal-title":"Health Econ Policy Law"},{"key":"10.1016\/j.cgh.2017.09.031_bib21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1148\/radiol.15141864","article-title":"Evaluation of the effect of cumulative operator experience on hepatocellular carcinoma recurrence after primary treatment with radiofrequency ablation","volume":"276","author":"Lee","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.cgh.2017.09.031_bib22","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/hep.28266","article-title":"Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation","volume":"63","author":"Lee","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.09.031_bib23","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A\u00a0class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.cgh.2017.09.031_bib24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3748\/wjg.v4.i5.392","article-title":"Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma","volume":"4","author":"Wang","year":"1998","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.09.031_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S1499-3872(12)60219-7","article-title":"Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma","volume":"11","author":"Zhou","year":"2012","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.cgh.2017.09.031_bib26","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1002\/hep.25914","article-title":"A\u00a0zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver","volume":"56","author":"Liu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2017.09.031_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2017.09.031_bib28","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1002\/ijc.28196","article-title":"Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism","volume":"133","author":"Zhou","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cgh.2017.09.031_bib29","doi-asserted-by":"crossref","first-page":"e69981","DOI":"10.1371\/journal.pone.0069981","article-title":"Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2017.09.031_bib30","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archsurg.1983.01390080088022","article-title":"Carcinoma in choledochal cysts: age-related incidence","volume":"118","author":"Voyles","year":"1983","journal-title":"Arch Surg"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517311667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517311667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:24:23Z","timestamp":1761542663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356517311667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S1542356517311667"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2017.09.031","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2017.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the AGA Institute","name":"copyright","label":"Copyright"}]}}